Mangalodayam Pharmaceuticals Private Limited, a active private limited company, was established on 27 June 2006 in Changaramkulam, Kerala, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U24239KL2006PTC019553. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹7.48 M.
It upholds a compliant status. Its leadership includes Puthiya Vettil Muhammed Asaraf (Director), Abdul Latheef Puthiya Veettil (Director), Puthiyaveettil Nabeeza (Director). It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at V/470A, Chiyyanoor Kokkur Po, Ponani Taluk, Changaramkulam, Kerala, 679591.
U24239KL2006PTC019553
019553
27 June 2006
₹8.00 M
₹7.48 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Mangalodayam Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Puthiya Vettil Muhammed Asaraf | Director | 27 Jun 2006 | Current |
| Abdul Latheef Puthiya Veettil | Director | 27 Jun 2006 | Current |
| Puthiyaveettil Nabeeza | Director | 27 Jun 2006 | Current |
| Puthiyaveettil Hussain Mohamed | Director | 27 Jun 2006 | Current |
| Puthiya Veettil Muhammad Sageer | Director | 27 Jun 2006 | Current |
| Mohammed Salahudheen | Director | 27 Jun 2006 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mangalodayam Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.47% increase. The company also saw a substantial improvement in profitability, with a 66.23% increase in profit. The company's net worth Soared by an impressive increase of 13.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Mangalodayam Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2023 | Hdfc Bank Limited | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mangalodayam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mangalodayam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangalodayam Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mangalodayam Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Mangalodayam Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 2.00 M with Charge ID 100856554 was registered on 17 Nov 2023. was recorded as a recent event.
Puthiya Vettil Muhammed Asaraf was appointed as a Director was appointed as a Director on 27 Jun 2006 & has been associated with this company since 19 years 5 months . was recorded as a recent event.
The activity Abdul Latheef Puthiya Veettil was appointed as a Director was appointed as a Director on 27 Jun 2006 & has been associated with this company since 19 years 5 months . was completed.
Puthiyaveettil Nabeeza was appointed as a Director was appointed as a Director on 27 Jun 2006 & has been associated with this company since 19 years 5 months . was recorded as a recent event.
The CIN of Mangalodayam Pharmaceuticals Private Limited is U24239KL2006PTC019553.
Mangalodayam Pharmaceuticals Private Limited is headquartered at V/470A, Chiyyanoor Kokkur Po, Ponani Taluk, Changaramkulam, Kerala, 679591.
Mangalodayam Pharmaceuticals Private Limited was incorporated on 27 June 2006.
The current directors of Mangalodayam Pharmaceuticals Private Limited are
The primary industry of Mangalodayam Pharmaceuticals Private Limited is Hospital And Medical Care.
Mangalodayam Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mangalodayam Pharmaceuticals Private Limited is ₹8.00 M, and the paid-up capital is ₹7.48 M.
The compliance status of Mangalodayam Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX